Page last updated: 2024-11-03

pyrimethamine and P carinii Infection

pyrimethamine has been researched along with P carinii Infection in 9 studies

Maloprim: contains above 2 cpds

Research Excerpts

ExcerptRelevanceReference
" Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T."1.30Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, L1
Jia, Q1
Kovacs, JA1
Nahimana, A2
Rabodonirina, M2
Zanetti, G1
Meneau, I1
Francioli, P2
Bille, J2
Hauser, PM2
Mehlhorn, H1
Dankert, W1
Hartman, PG1
Then, RL1
Hughes, WT1
Killmar, JT1
Oz, HS1
Brun-Pascaud, M3
Chau, F3
Simonpoli, AM1
Girard, PM3
Derouin, F3
Pocidalo, JJ1
Podzamczer, D1
Martos, A1
Ferrer, I1
Santin, M1
Gudiol, F1
Garry, L1
Jacobus, D1

Other Studies

9 other studies available for pyrimethamine and P carinii Infection

ArticleYear
Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Animals; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; Pneumocystis; Pneumocystis In

2002
Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
    The Journal of infectious diseases, 2003, Oct-01, Volume: 188, Issue:7

    Topics: Adolescent; Adult; Aged; Alleles; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bronchoalveolar Lav

2003
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cloning, Molecular;

2004
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Parasitology research, 1995, Volume: 81, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; F

1995
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    The Journal of infectious diseases, 1994, Volume: 170, Issue:4

    Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Tria

1994
Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    The Journal of infectious diseases, 1994, Volume: 170, Issue:3

    Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Brain; Dapsone; Drug Therapy, Combinat

1994
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Humans; Liver Dise

1993
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid

1996
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl B

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons

1998